President Trump at a presser on Thursday discussed the promising use of an on-the-shelf anti-malarial compound, hydroxychloroquine, for coronavirus. Besides coronavirus, the drug is used to treat rheumatoid arthritis and lupus. Its cheap and relatively safe. More accurately, hydroxychloroquine is combined with zinc and the antibiotic Zithromax, generically known as azithromycin.
The FDA at the presser said it was setting up a large clinical trial to evaluate the drug. View the following presser from minute 00:39:40.
It’s important to note this does not prevent infection but rather is a treatment that reduces the dangerous effects of the virus.
Oncologist William Grace does a great job of explaining how this works. (Right click for playback controls.)
There are some side effects, such as serious heart disease and retinal damage, but only among those who do the regimen longer-term, such as those with lupas or arthritis — not a 10-day/short-duration regimen.
It was good news. And yet, almost immediately, we saw strange nit-picking, tit-for-tat, making this development all about Trump. Clearly, The New York Times (aka The NY Slimes) completely lacks journalistic integrity and is endlessly biased on a number of fronts.
The Slimes felt compelled to turn the announcement into a World Wide Wrestling match by essentially labeling it as just some new Trump crackpot idea. It ran a fake news story titled “With Minimal Evidence, Trump Asks F.D.A. to Study Malaria Drugs for Coronavirus.” This politicization about the treatment is seen elsewhere among the usual suspect cognoscenti.
Could it be that successful treatment mitigates the need for The NY Slimes and their posse’s larger-agenda vaccines and expensive drugs?
The Slimes claims the drug went into short supply in the U.S. this month, as word has spread of its potential benefit to coronavirus patients. Then the story goes on to say, as an afterthought, that manufacturers were quickly gearing up pill production.
Today we announced a commitment to donate up to 130 million doses of hydroxychloroquine to support the global #COVID19 pandemic response. 1/5
— NovartisNews (@NovartisNews) March 20, 2020
The NY Slimes goes on to call the treatment a “remedy,” and then claimed in a hyperbolic headline that “Trump’s Embrace of Unproven Drugs to Treat Coronavirus Defies Science.” But is this headline even remotely true?
Chloroquine gets the zinc inside the cell membrane, where it inhabits the virus, and azithromycin blocks protein synthesis needed for virus regeneration.
The cellular process is explained in this clip.
Now comes a renowned research professor Didier Raoult in France reporting successful results from this new treatment for Covid-19, with early tests suggesting it can stop the virus from being contagious in just six days.
The treatment was offered to 24 patients, who were among the first to become infected in the southeast of France, and who had voluntarily admitted themselves to hospital for the process. Patients were given 600 mcg per day for 10 days.
“We were able to ascertain that patients who had not received Plaquenil [a drug containing hydroxychloroquine] were still contagious after six days, but of those that had received Plaquenil [hydroxychloroquine], after six days, only 25% were still contagious,” he reported.
Six other patients treated with hydroxychloroquine and antibiotic azithromycin were 100% were negative after six days.
A new academic study, published on Friday, March 13 by U.S. scientific researchers also said that chloroquine appeared to be an effective treatment and appears to align with the findings in France.
It said: “Use of chloroquine (tablets) is showing favorable outcomes in humans infected with Coronavirus, including faster time to recovery and shorter hospital stay.”
A Dutch scientist of the University of Groningen created #hydroxychloroquine in aerosol form and it will be available within weeks. It instantly reaches the lungs to directly block the negative effects of #COVID19, even better than HCQ in oral form.
— [REDACTED] (@CRYP7KEEPER) March 20, 2020
This is the study about Zn2 as a coronavirus combination inhibitor.
Elsewhere, a new study published in the prestigious journal “Vaccine” — a peer-reviewed medical journal published by Elsevier — titled “Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season” reveals that influenza vaccination may increase the risk of infection from other respiratory viruses by 36%, such as coronavirus. The phenomenon is known as virus interference.
And once again, that contrarian lugenpresse indicator, The New York Slimes, engages in sketchy observations.
Winter Watch Takeaway
Our bet is that with the POTUS behind this, the treatment of coronavirus itself will be greatly enhanced and the effects mitigated. The aggressive go ahead will likely come in a few short weeks. Then, people who are still dying or severely ill are suffering from disease completely separate from coronavirus.
Policymakers will then have to more carefully weigh the extremely draconian negative and damaging social-economic impacts of lock downs and quarantine overreaction. But the biggest deadly side effect of coronavirus is less and less about the virus itself but rather the Black Swan effects of massive debt-fueled bankrupting stimulus, looting operations and money printing resulting from a popping financial bubble.
As far as Trump’s script in all this, have no doubt that it is New Underworld Order authoritarian: DOJ Wants to Suspend Constitutional Rights During Coronavirus Emergency
And inquiring minds would like to know: Did the powers that/to be already know that hydroxychloroquine combined with zinc and Zithromax was the cure all along before they triggered this panic and psyop?
Important Update: They knew about chloroquine as effective treatment all along!